B.Sc. University of Liverpool, 1993
Ph.D. University of Liverpool, 1997
Senior Research Scientist, Vancouver Prostate Centre
Co-Director, Pharmacology and Drug Design, Vancouver Prostate Centre
Associate Professor, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia
Associate Member, Faculty of Pharmaceutical Sciences, University of British Columbia
Associate Member, Department of Advanced Therapeutics, BC Cancer Agency
Dr. Emma Tomlinson Guns is an Associate Professor in the Department of Urologic Sciences, Faculty of Medicine at UBC. She co-directs the Pharmacology and Drug Design Core at the Vancouver Prostate Centre and has completed pharmacokinetic analyses for numerous local clinical trials with conventional therapeutics for the treatment of prostate cancer (PCa). Her research group has received > $4 million in research funding during the past 10 years for research focused on several areas pertaining to the development, treatment and progression of PCa and she has published > 50 original articles. In conjunction with her core responsibilities at VPC, Dr Guns’ research group recently helped redefine an important resistance phenomena involved in castration resistant progression, i.e. tumour derived steroid formation. Her lab has also more recently developed an interest in microvesicles as conveyors of treatment resistance and cell survival signaling during cancer progression. Another significant aspect of her research is orientated around the use of natural health products (NHPs) and dietary supplements by prostate cancer patients and, in addition to her being a current board member for the Society for Integrative Oncology (http://www.integrativeonc.org/), she is a co-founder and former President (2011-2013) of the Natural Health Products Research Society of Canada (www.nhprs.ca). The concurrent use of NHPs with conventional chemotherapeutics/treatment strategies have been an important focus and interest of her lab - to help patients and caregivers to discern both beneficial and adverse interactions with NHPs. Dr. Guns has served/sits on a number of grant review panels including the US DoD, CCSRI, PCF/Movember UK, CIHR, PCFRC and MSFHR.